On June 19, 2025, Canada’s Drug Agency (“CDA”) opened a public consultation to gather input on a proposed list of essential prescription drugs and related products. This initiative is part of the agency’s responsibilities...more
On February 27, 2025, the Government of Canada and Manitoba signed the first national pharmacare agreements under Canada’s Bill C-64, An Act respecting pharmacare (the “Pharmacare Act”), which received royal assent on October...more
3/11/2025
/ Canada ,
Drug Pricing ,
Government Agencies ,
Health Insurance ,
Health Technology ,
Healthcare ,
Healthcare Reform ,
New Legislation ,
Pharmaceutical Industry ,
Prescription Drugs ,
Public Health
Canada’s Bill C-64, An Act respecting pharmacare (the “Pharmacare Act”) received royal assent on October 10, 2024 and established a framework for national pharmacare. On February 27, 2025, the Hon. Mark Holland, Canada’s...more
On December 28, 2024, Health Canada published a regulatory proposal in the Canada Gazette, Part I, Volume 158, Number 52, introducing amendments to the Food and Drug Regulations, CRC, c 870 and the Medical Devices...more
1/20/2025
/ Canada ,
Health Canada ,
Life Sciences ,
Medical Devices ,
Pharmaceutical Industry ,
Proposed Amendments ,
Proposed Rules ,
Public Health ,
Regulatory Agenda ,
Reporting Requirements ,
Supply Chain
The Regulations Amending Certain Regulations Concerning the Disclosure of Cosmetic Ingredients (SOR/2024-63) (the “Amended Cosmetic Regulations), published on April 24, 2024, took effect on October 9th (with the exception of...more
10/17/2024
/ Canada ,
Consumer Product Companies ,
Cosmetics ,
Manufacturers ,
New Regulations ,
Personal Care Products ,
Popular ,
Product Labels ,
Public Health ,
Regulatory Reform ,
Retail Market